Abstract
687P A CRUK phase I/IIA, first in human dose-escalation and expansion trial of HMBD-001 (an anti-HER3 antibody) in patients with advanced HER3 positive solid tumours
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have